Search Results - "FEDERICO PERNO, Carlo"
-
1
Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)
Published in PloS one (21-09-2022)“…The SARS-CoV-2 pandemic is a global threat affecting 210 countries, with 2,177,469 confirmed cases and 6.67% case fatality rate as of April 16, 2020. In…”
Get full text
Journal Article -
2
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection
Published in Journal of acquired immune deficiency syndromes (1999) (01-06-2018)“…ABSTRACTInnovation in medicine is a dynamic, complex, and continuous process that cannot be isolated to a single moment in time. Anniversaries offer…”
Get full text
Journal Article -
3
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression
Published in Hepatology (Baltimore, Md.) (01-03-2015)“…Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated…”
Get full text
Journal Article -
4
Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol
Published in PloS one (09-08-2022)“…Background COVID-19 has been the most important public health concern worldwide since 2020. Several vaccines are now available to help in controlling COVID-19…”
Get full text
Journal Article -
5
Evaluation of archived drug resistance mutations in HIV‐1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID‐19 pandemic
Published in HIV medicine (01-06-2023)“…Background With the success of antiretroviral therapy (ART), children born with HIV are more likely to reach adolescence. However, frequent non‐adherence to…”
Get full text
Journal Article -
6
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients
Published in Scientific reports (26-01-2022)“…Response to ritonavir-boosted-protease inhibitors (PI/r)-based regimen is associated with some Gag mutations among HIV-1 B-clade. There is limited data on Gag…”
Get full text
Journal Article -
7
HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
Published in PloS one (01-07-2021)“…Some mutations in the HIV-1 Gag gene are known to confer resistance to ritonavir-boosted protease inhibitors (PI/r), but their clinical implications remain…”
Get full text
Journal Article -
8
A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
Published in Journal of viral hepatitis (01-07-2019)“…The study was undertaken in order to provide a snapshot from real clinical practice of virological presentation and outcome of patients developing…”
Get full text
Journal Article -
9
Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon
Published in PloS one (21-07-2020)“…Background With the scale-up of antiretroviral therapy (ART), pre-treatment drug resistance (PDR) appears [greater than or equal to]10% amongst ART-initiators…”
Get full text
Journal Article -
10
Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
Published in BMJ open (10-10-2023)“…IntroductionThe success of antiretroviral therapy (ART) has changed HIV from a deadly to a chronic infection, thus increasing the transitioning from infancy…”
Get full text
Journal Article -
11
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
Published in Frontiers in immunology (08-03-2023)“…The lower burden of COVID-19 in tropical settings may be due to preexisting cross-immunity, which might vary according to geographical locations and potential…”
Get full text
Journal Article -
12
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
Published in Viruses (01-08-2023)“…Increased HIV drug resistance (HIVDR) with antiretroviral therapy (ART) rollout may jeopardize therapeutic options, especially in this era of transition to…”
Get full text
Journal Article -
13
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
Published in Viruses (28-06-2023)“…The efficacy of first-line antiretroviral therapy (ART) may be hampered by the presence of HIV drug resistance (HIVDR). We described HIV-1 pre-treatment drug…”
Get full text
Journal Article -
14
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat"
Published in AIDS research and therapy (19-11-2019)“…After the launching of the « Test & Treat » strategy and the wider accessibility to viral load (VL), evaluating virological success (VS) would help in meeting…”
Get full text
Journal Article -
15
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon
Published in BMC infectious diseases (12-03-2019)“…With the phase-out of stavudine (d4T), change to first-line regimens with zidovudine (AZT) or tenofovir (TDF) in resource-limited settings (RLS) might increase…”
Get full text
Journal Article -
16
Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
Published in BMC pediatrics (05-07-2019)“…Sub-Saharan Africa (SSA) alone has nine out of every 10 children living with HIV globally and monitoring in this setting remains suboptimal, even as these…”
Get full text
Journal Article -
17
Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing
Published in The Journal of infectious diseases (15-02-2012)“…Background. The dynamics of raltegravir-resistant variants and their impact on virologie response in 23 HIV-1-infected patients, who started a salvage…”
Get full text
Journal Article -
18
Overcoming resistance to existing therapies in HIV-infected patients: The role of new antiretroviral drugs
Published in Journal of medical virology (01-04-2008)“…Resistance to available antiretroviral (ARV) agents is of increasing concern, and development of novel agents that address this problem has been identified as…”
Get full text
Journal Article -
19
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
Published in AIDS research and therapy (12-05-2020)“…The high rate of mortality among HIV-vertically infected adolescents might be favoured by HIV drug resistance (HIVDR) emergence, which calls for timeous…”
Get full text
Journal Article -
20
Identification of Merkel cell polyomavirus in the lower respiratory tract of Italian patients
Published in Journal of medical virology (01-03-2010)“…Merkel cell polyomavirus (MCPyV) has been found to be integrated monoclonally in a rare skin cancer named Merkel cell carcinoma. More recently, MCPyV has been…”
Get full text
Journal Article